Want to see NZ:PHL full AI Analyst Report?
Top Page
Promisia Healthcare Limited
(PHL)
Select Model
Select Model
Rating:63Neutral
Price Target:
$0.67
Action:N/A
Date:10/05/26
The score is supported primarily by improved financial performance (strong FY2026 profitability and reduced leverage) and a very low P/E valuation. These positives are tempered by mixed cash-flow reliability and weak technical signals (price below key moving averages with negative MACD and low RSI/stochastic).
Positive Factors
Profitability and revenue growth
The combination of meaningful revenue growth and a sharp increase in net margin indicates stronger earnings capacity entering the next several months. If profitability remains near FY2026 levels, Promisia can generate more internal resources to support operations, investment, and balance-sheet improvement.
Negative Factors
Inconsistent cash generation
Although FY2026 cash flow improved, the history of negative free cash flow shows that earnings have not consistently translated into cash. Uneven conversion can constrain internally funded investment, create greater reliance on financing, and make future cash-based shareholder returns less predictable.
Read all positive and negative factors
Positive Factors
Negative Factors
Profitability and revenue growth
The combination of meaningful revenue growth and a sharp increase in net margin indicates stronger earnings capacity entering the next several months. If profitability remains near FY2026 levels, Promisia can generate more internal resources to support operations, investment, and balance-sheet improvement.
Read all positive factors
Promisia Healthcare Limited (PHL) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$34.15M
Dividend YieldN/A
Average Volume (3M)9.51K
Price to Earnings (P/E)<0.1
Beta (1Y)0.59
Revenue Growth29.55%
EPS Growth-11.97%
CountryNZ
Employees467
SectorGeneral
Sector StrengthN/A
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)24.52
Shares Outstanding54,206,650
10 Day Avg. Volume3,320
30 Day Avg. Volume9,506
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)<0.01
Price to Sales (P/S)0.00617
P/FCF Ratio0.04
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Promisia Healthcare Limited Business Overview & Revenue Model
Company Description
Promisia Healthcare Limited engages in the aged care and retirement living business in New Zealand. It offers a range of living options, such as rest home, dementia, respite, young disabled, palliative, and hospital care, as well as independent li...
Promisia Healthcare Limited Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
62
Positive
Cash Flow
55
Neutral
| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 40.12M | 29.69M | 24.17M | 23.46M | 20.12M |
| Gross Profit | 37.86M | 29.69M | 24.17M | 23.46M | 20.12M |
| EBITDA | 6.41M | 9.99M | 7.09M | 3.50M | 5.31M |
| Net Income | 12.92M | 6.84M | 1.64M | 614.00K | 2.22M |
Balance Sheet | |||||
| Total Assets | 199.50M | 172.09M | 84.34M | 71.75M | 51.76M |
| Cash, Cash Equivalents and Short-Term Investments | 110.00K | 132.00K | 198.00K | 2.06M | 2.41M |
| Total Debt | 41.63M | 121.75M | 73.71M | 46.33M | 17.15M |
| Total Liabilities | 144.30M | 132.81M | 59.47M | 51.66M | 33.18M |
| Stockholders Equity | 55.20M | 39.27M | 28.66M | 20.09M | 18.58M |
Cash Flow | |||||
| Free Cash Flow | 5.83M | 3.12M | 7.17M | -6.81M | 2.75M |
| Operating Cash Flow | 6.36M | 3.40M | 7.49M | 7.07M | 4.79M |
| Investing Cash Flow | 122.00K | -10.56M | -7.60M | -21.14M | -2.04M |
| Financing Cash Flow | -6.50M | 7.17M | -1.83M | 13.72M | -1.55M |
Promisia Healthcare Limited Technical Analysis
Negative
―
Price Trends
0.70
Negative
0.66
Negative
0.56
Positive
Market Momentum
-0.01
Positive
40.48
Neutral
3.92
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NZ:PHL, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 0.67, equal to the 50-day MA of 0.70, and equal to the 200-day MA of 0.56, indicating a neutral trend. The MACD of -0.01 indicates Positive momentum. The RSI at 40.48 is Neutral, neither overbought nor oversold. The STOCH value of 3.92 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NZ:PHL.
Promisia Healthcare Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | $45.49M | 16.07 | ― | 3.60% | 17.86% | 20.79% | |
66 Neutral | $1.76B | 5.65 | 8.89% | 2.43% | 14.09% | -18.30% | |
63 Neutral | $34.15M | 0.03 | ― | ― | 29.55% | -11.97% | |
56 Neutral | $1.83B | -10.88 | -4.17% | 3.15% | 11.86% | 72.99% | |
56 Neutral | $114.80M | 12.16 | ― | 4.23% | 14.16% | 34.82% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
50 Neutral | $514.20M | 3,525.00 | 0.02% | 4.16% | 2.52% | -99.52% |
* General Sector Average
NZ:PHL
Promisia Healthcare Limited
0.65
0.22
50.00%
NZ:OCA
Oceania Healthcare
0.70
-0.02
-2.78%
NZ:RYM
Ryman Healthcare
1.80
-1.09
-37.67%
NZ:SUM
Summerset Group Holdings Limited
7.04
-4.01
-36.26%
NZ:TAH
Third Age Health Services Limited
4.46
0.03
0.72%
NZ:RAD
Radius Residential Care Ltd
0.40
0.06
18.34%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.